Zepbound 7.5 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FA3JL
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,992
Award facts
- Contract value 100% obligated
- $10,992.22 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $10,992.22 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Zepbound 7.5 mg/0.5 mL pen injections. This non-set-aside award is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, with ultimate completion scheduled for September 8, 2025. Zepbound is a GLP-1 receptor agonist medication used in the management of weight loss and metabolic conditions.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement through its Pharmaceutical Prime Vendor Global Program vehicle with DLA. The company's extensive federal contract portfolio demonstrates consistent capability to supply a comprehensive range of pharmaceutical products, medical devices, and specialized healthcare commodities to support military healthcare systems worldwide. This delivery order represents one of numerous competitively awarded transactions fulfilling the Defense Health Agency and broader Department of Defense pharmaceutical supply requirements across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DB25FA3JL?
SPE2DB25FA3JL was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 5, 2025.
How much is contract SPE2DB25FA3JL worth?
The government has obligated $10,992 on SPE2DB25FA3JL.
Is contract SPE2DB25FA3JL an order under another contract?
Yes. SPE2DB25FA3JL is a delivery order under SPE2DB20D3303, an indefinite delivery contract.
Was contract SPE2DB25FA3JL competed?
The extent of competition for SPE2DB25FA3JL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award